Celgene announces offering of senior unsecured notes

|By:, SA News Editor

Celgene (CELG) intends to offer, subject to market and other conditions, senior unsecured notes under a shelf registration statement.

Interest rate, maturity dates and other key terms of the offering to be determined at the time of pricing.

CELG will use the net proceeds from the offering for general corporate purposes, "which may include, without limitation, further development of Celgene's clinical and pre-clinical programs, capital expenditures, general corporate development activities, meeting working capital needs, share repurchases of Celgenes common stock and repayment of some or all of Celgenes outstanding commercial paper."

Barclays (BCS) Citigroup (C), Deutsche Bank Securities (DB) and J.P. Morgan (JPM) acting as joint book-running managers.